在非小細胞肺癌病人其免疫系統之變化及免疫原性細胞死亡與治療預後的關係

Medicine & Life Sciences

1. Myeloid-Derived Suppressor Cells 100%
2. Immunogenic Cell Death 67%
3. Lung Neoplasms 59%
4. Drug Therapy 56%
5. Neoplasms 24%
6. Coculture Techniques 21%
7. Immunotherapy 18%
8. T-Lymphocytes 13%
9. Therapeutics 12%
10. Antigen-Presenting Cells 11%
11. Oligonucleotide Array Sequence Analysis 11%
12. Regulatory T-Lymphocytes 10%
13. Natural Killer Cells 9%
14. Dendritic Cells 9%
15. Non-Small Cell Lung Carcinoma 9%
16. Necrosis 8%
17. Cell Death 8%
18. Direction compound 7%
19. Pharmacology 7%
20. Cell Proliferation 7%
21. Biomarkers 6%
22. Neoplasm Metastasis 6%
23. Cell Line 6%
24. Survival 5%
25. Antibodies 5%